Skip to search formSkip to main contentSkip to account menu

antineoplaston A2

Known as: antineoplaston-A2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
This paper describes Phase I clinical studies of Antineoplaston A2 injections. The studies involved 15 patients diagnosed with… 
1986
1986
Antineoplaston A2, 25 mg/ml, was administered to mice in the form of daily intraperitoneal injections for 270 days. The mice were…